Bioethics Governance World Health 
Bill of Health
JUNE 28, 2023
By Donrich Thaldar On the issue of human genome editing (HGE), attitudes between bioethics scholars and the general public diverge, as highlighted by my team’s findings from a recent deliberative public engagement study. ” (Not one study participant relied on this objection during the more than 20 hours of deliberations.)
Jane Sarashon
JANUARY 24, 2024
WHO has released guidance on the use of large multi-modal models (LMMs) in health care which detail 40+ recommendations for stakeholders in the field to consider when deploying AI. The post Ethics for AI in Health – A View From The World Health Organization appeared first on HealthPopuli.com.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
DECEMBER 12, 2024
But the disappointment surrounding financing outcomes was merely a symptom of deeper power imbalances, what critical legal scholar Martti Koskenniemi describes as the “structural biases” of global governance institutions. Yet this progress was not abstracted from the structural bias shaping the broader climate governance regime.
Health Populi
SEPTEMBER 6, 2023
“I’m in Berlin, and we don’t like walls,” Bart De Witte responded in a concluding Q&A session yesterday at the 2 nd Symposium on the Future of Health Systems, convened by the World Health Organization (WHO) in Porto on 5 th September.
Health Populi
JUNE 5, 2024
How AI can democratize and enchant health care – the WHO perspective In January 2024 I explored the World Health Organization’s report on Ethics & Governance of Artificial Intelligence for Health in my Health Populi blog. Let me explain from a global to a local lens….
Bill of Health
OCTOBER 24, 2023
This symposium gathers reflections from leading scholars, activists, jurists, and others from around the world with respect to the recently issued Principles. Historically, Global Health Law has been permeated with colonialism and concerned with preserving travel and trade rather than protecting human dignity, health and life.
Bill of Health
JANUARY 31, 2022
The Delta variant led the federal government to resume control over mAb supply and promulgate allocation guidelines. Over the past few months, we have seen the arrival and wider availability of treatments such as monoclonal antibodies (mAbs), and more recently, of novel oral antiviral drugs like Paxlovid and molnupiravir.
Expert insights. Personalized for you.
147 
Let's personalize your content